MedTrace Logo

Confocal Laser Endomicroscopy in Digestive Diseases

NCT01156064 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2010-11-23

No results posted yet for this study

Summary

Confocal laser endomicroscopy (CLE) is a newly endoscopic device that enables microscopic view of the digestive tract. The purpose of this study is to determine if confocal laser endomicroscopy can improve detection of digestive disease include inflammation, dysplasia, and early cancer, and if confocal laser endomicroscopy has competitive advantage, compared with other device such as Narrow Band Imaging and Autofluoresecence Imaging.

Conditions

  • Digestive System Diseases

Interventions

DEVICE

Confocal Laser Endomicroscopy (Pentax/Optiscan)

Confocal laser endomicroscopy is performed using the Pentax/Optiscan confocal endomicroscopy and 5 ml of 10% intravenous fluorescein sodium. Photos of magnified images of the digestive mucosa are taken during the procedure.

DEVICE

Narrow Band Imaging/Auto Fluorescence Imaging (Olympus)

NBI/AFI endoscope offers an alternative light source involve NBI and AFI to view digestive mucosa in real time.

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Yunsheng Yang, MD · Chinese PLA General Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-12-31
Completion
2011-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01156064 on ClinicalTrials.gov